MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problems
Failure to Interrogate (1332); Data Problem (3196)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/29/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
Concomitant medical products: product id a810, serial# unknown, product type software.Other relevant device(s) are: product id: a810, serial/lot #: unknown.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was receiving morphine with concentration 25 mg/ml at a dose rate of 12.1, maximum 24 hours 13.53, via an implantable pump for non-malignant pain.It was reported that the company representative was in the clinic today and this patient was having a routine normal pump refill.Upon interrogation, the healthcare provider stated they received service code 101 and in the event logs there were three events for the time they interrogated the pump at 1:11 pm.The three events were event code 01 critical alarm- reset occurred , 07 critical alarm- pump defaulted to minimum rate, and 2c critical alarm- pump reset due to firmware error.The hcp denied any falls/trauma/radiation therapy for this patient.The infusion was listed as minimum rate, however the rest of the programming is accurate.At the time of the report technical services instructed to silence the alarms and then go through each tab and re-enter the infusion rate.They silenced the alarm, then corrected the rate, and the healthcare provider had updated the pump successfully.They then re-read the pump logs which showed the events were cleared and troubleshooting had resolved the issue.The clinician programmer software application version being used at the time of the event was version (b)(6).It was further noted that there was no abnormal logs prior to todays refill.
|
|
Manufacturer Narrative
|
H10 update: this device issue is known and documented in the labeling per ma04279a071 ¿ n¿vision clinician programmer with software synchromed ii infusion systems.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received reported that the patient had no symptoms or issues.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|